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Introduction
Depressive disorders are among the top ten causes of the global burden of disabilityadjusted life-years (DALYs) 1 . People living with HIV (PLHIV) are more likely to experience depression than HIV-uninfected people [2] [3] [4] . Several individual studies and meta-analyses link depression to adverse HIV-related outcomes among PLHIV, including lower antiretroviral therapy (ART) uptake and adherence and reduced overall health status [4] [5] [6] . Few studies have assessed the relationship of postpartum depression (PPD) and prevention of mother to child transmission (PMTCT) outcomes among HIV-infected mothers 1, 2 . Even less data are currently available on PPD among mothers living with HIV in low and middle-income countries (LMICs) 6 . Therefore, the impact of PPD among HIV-infected mothers on PMTCT outcomes within LMICs is not well understood.
PPD can decrease a mother's engagement in health promotion activities 7, 8 . Among HIVinfected mothers, this could negatively influence uptake of and adherence to PMTCT services (including antenatal care attendance, HIV testing and ARVs) which, in turn, could increase MTCT. The impact of PPD on PMTCT outcomes could have significant implications, particularly in regions with high maternal HIV burden and where MTCT persists as a public health challenge. To date, few studies have reported the prevalence of PPD in Kenya and none have evaluated the relationship of PPD and PMTCT outcomes among HIV-infected mothers 9 .
We assessed the prevalence of PPD among HIV-infected postpartum mothers in Kenya and evaluated the relationship between PPD and PMTCT outcomes, including uptake of maternal and infant antiretrovirals (ARVs) for PMTCT and MTCT.
Methods

Study Design and Data Sources
We conducted a secondary analysis using data from a large cross-sectional survey of mother-infant pairs 10 . The parent survey was conducted in 141 MCH clinics across Kenya between June and December 2013 and collected data from mother-infant pairs attending clinic for 6-week and 9-month infant immunizations. The overall aim of the parent study was to evaluate prevalence of HIV among postpartum mothers and MTCT. Facility selection, sampling, and survey methods have been previously described 3 . Briefly, probability proportionate to size (PPS) sampling was used to randomly sample facilities and all eligible mother-infant pairs attending selected facilities during a fixed 5-day recruitment period were recruited. For the current analyses, we restricted the dataset to only HIV-positive mothers.
Standardized questionnaires were administered by study nurses to obtain information on socio-demographic characteristics, obstetric history, and maternal and infant health indicators.
Maternal HIV status and ARV use by mothers and infants was self-reported by mothers and verified by the women's Maternal & Child Health Booklet. Dimensions of HIV-related stigma and discrimination were assessed using a validated toolkit developed to assess blame/judgment and moral values of shame 11, 12 . Experience of intimate partner violence (IPV) within the past 6 months was assessed using Hurt, insulted, Threatened with Harm and Screamed (HiTS) domestic violence screening tool 4 . Maternal depression was assessed using the Patient Health Questionnaire (PHQ)-9 which has been validated for use in Kenya 13 . According to Kroenke and Spitzer (2002) , moderate depression is defined as a PHQ-9 score >10 14 . A meta-analysis of PHQ-9 utilization determined that an optimal cutoff score range between 8 and 11 yielded no differences in the diagnostic performance (sensitivity or specificity) 15 . We defined depression as a having a PHQ-9 score >8.
Laboratory procedures have previously been described in detail 3 . Briefly, infant HIV testing was conducted using dry blood spot (DBS) specimen DNA polymerase chain reaction (PCR). DBS were sent to KEMRI-CDC national laboratory and PCR results were returned to clinics who then provided results to mothers per national guidelines. Support services and HIV care referrals were made for mothers whose infants tested positive 10 .
Statistical Analysis
Analyses included only HIV-infected mothers. Descriptive statistics were used to identify differences between postpartum mothers with and without depression. All models accounted for clinic-level clustering. We also performed sensitivity analyses by repeating the primary analysis using cutoff of PHQ-9 >10 to reduce potential misclassification.
Results
Overall, 498 mothers met inclusion criteria and were included in this analysis; 52% were attending 6-week postnatal visits and 48% 9-month visits. The median age of mothers was 28 years (IQR 24-32), 17% of women were unmarried, and the median relationship length among those with male partners was 5 years (IQR 3-10). The average years of completed education was 8 (IQR 7-11). Women had a median of 3 (IQR=2-4) living children. Overall, 6% of women had PHQ-9 scores ≥8; 5% among women attending 6-week visits and 7% attending 9-month visits.
Women who experienced IPV in the past 6 months were more likely to have depression than women who did not experience IPV (39% vs 12%, respectively, p<0.001). We did not detect differences in other demographic, relationship, or clinical characteristics between women with and without depression ( Table 1) .
Stigma and Discrimination
One-fourth (26%) of women agreed with the statement "HIV is a punishment from God".
Women with depression more frequently agreed with the statement, "People living with HIV are promiscuous", than women without depression (28% vs 11%, p=0.032). We did not detect differences between women with and without depression in the frequency of other measures of externalized and internalized HIV stigma (Table 1) . Overall, frequency of experiencing discrimination within the last year because of one's HIV status was <10% for all acts of discrimination assessed. Women with depression were significantly more likely to experience acts of discrimination due to their HIV status than women without depression, including being abandoned by family members (p=0.004), excluded from family and social gatherings (p=0.002), losing employment (p=0.001) or housing (p<0.001) and standing in community (p=0.027) ( Table   1 ). Among women with depression, the most frequently reported acts of discrimination were losing jobs/customers (26%), being abandoned by their spouse (23%), being excluded from social gatherings (19%), and losing standing within the family or community (19%).
PMTCT Outcomes
Among all women, 81% of women reported use of maternal ARVs during all time points (pregnancy, labor, and breastfeeding). We did not detect differences between maternal uptake of ARVs during pregnancy, labor, or breastfeeding among women with and without depression (Table 2) .
Overall, 4% of infants attending 6-week immunization visits were HIV-positive and 5%
of infants attending 9-month visits were HIV-positive. with HIV during study procedures; one 9-month old infant was diagnosed with HIV prior to the survey. Analyses using a cutoff of PHQ-9 >10 data produced results that were very similar to our primary models, though statistical power was limited (data not shown).
Discussion
In this study, 6% of HIV-infected women surveyed at 6 weeks or 9 months postpartum had moderate depression. Maternal depression was significantly associated with externalized stigma and discrimination but not internalized stigma. Maternal depression was also associated with non-use of infant antiretroviral prophylaxis and higher likelihood of infant HIV infection.
To our knowledge, no other studies to date have evaluated the relationship between postpartum depression and MTCT. Our results highlight the need for additional research and mental health services for HIV-infected mothers experiencing depression, especially within the context of LMICs where MTCT persists as a public health problem.
LMIC settings have limited resources for mental health care as few practitioners are trained on screening and treating mental health issues 16 . PPD affects women at a critical period in the lives of both mothers and infants and is common, with some studies reporting rates of PPD between 5-35% in LMICs 5 . In HIV-uninfected populations, PPD has been associated with risk of poor infant outcomes, including poor postnatal growth, obesity, and neurocognitive delays [6] [7] [8] .
PPD among HIV-infected mothers has previously been associated with adverse outcomes such as increased infant withdrawal symptoms, higher rates of infant wheezing, and lower rates of exclusive breastfeeding 23, 24 . HIV-infected individuals may experience nearly twice the rate of depression compared to HIV-uninfected individuals [2] [3] [4] . In the context of LMIC settings with high HIV burden, this could translate to a substantial burden of PPD and sequelae among HIVinfected mothers and underscores the need for improving PPD screening and treatment services for this population.
Using the PHQ-9 tool, we found that prevalence of PPD was <10% among postpartum women across 141 clinics in Kenya. To date, only one small study has evaluated PPD among HIV-infected women in Kenya, finding that 48% of attendees at the Kenyatta National Hospital PMTCT clinic, located in Nairobi, screened positive for depressive symptoms using the Edinburgh Postnatal Depression Scale (EPDS) 9 . The EPDS has not been previously validated in Kenya and the study was solely based in one large, urban facility, which may account for the differences in PPD prevalence. Future validation studies that assess the PHQ-9 and EPDS within the same study population could be useful to understanding the most culturally appropriate and valid tool for PPD screening in Kenya.
We found that depressed women more frequently experienced acts of discrimination because of their HIV status, similar to other studies 12 . This included substantial losses-being abandoned by one's partner and family, isolation, losing houses, property, jobs, and social standing. Unlike other studies, we did not detect differences in internalized or externalized stigma between mothers with and without depression 25, 26 . This could be due to our sampling which only included mother-infant pairs attending scheduled immunization appointments at MCH clinics. It is possible that stigmatized mothers may be less likely to attend clinic. Despite ongoing global efforts to reduce HIV-related stigma and discrimination, our results indicate that additional programs are needed with nearly one-fourth of depressed women reporting they had been abandoned by their spouse due to their HIV status. Consistent with findings in other parts of sub-Saharan Africa, we also found an association between IPV and PPD 27, 28 . Screening for both IPV and PPD within the context of PMTCT programs could help identify postpartum women in greatest need of interventions.
Our study has limitations. We used cross-sectional data and therefore MTCT could have occurred before mothers' depressive symptoms and led to maternal depression. However, 3 of the 4 cases were detected after the diagnosis of depression at the survey, making this unlikely.
Although the PHQ-9 depression-screening tool has been validated in Kenya, other screening tools, such as the EPDS, may yield different results. Additionally, statistical power was limited due to the relatively small number of infant HIV infections, therefore we did not conduct multivariate statistical models.
In conclusion, PPD was associated with increased likelihood of MTCT and lower likelihood of infant receipt of ARV prophylaxis for PMTCT. Postpartum mothers with depression were also more likely to experience discrimination. Our results underscore the need for continued efforts to reduce HIV-related stigma and discrimination. Our findings also support expanding depression screening and psychosocial services within the context of PMTCT clinical settings to improve both maternal mental health and infant outcomes. 
